• World Breastfeeding Week: 10 essential nutrition tips for mothers
    New Delhi, August 6 (IANSlife): For women who have recently become mothers, a healthy and nutritious diet is essential to boost lactation, just as much as its essential for a newborn to get its share of required nutrition. This makes it mandatory for the mother to consume food that will benefit her physical health and give her enough energy to combat post-pregnancy pressures, especially with the pandemic disrupting our daily lives. This World Breastfeeding Week, Rohit Shelatkar, VP
  • Russia bats for safety of its Covid-19 vaccine
    Moscow, August 4 (IANS) The Russian Ministry of Defence has said that a Covid-19 vaccine that it developed in partnership with the Gamaleya Scientific Research Institute of Epidemiology and Microbiology appears to be safe. On August 3, a "final medical examination" of participants in clinical trials of the vaccine took place at the Burdenko Main Military Clinical Hospital, it said in a statement. The results clearly showed that all volunteers had a clear immune response
  • Sun Pharma launches Favipiravir as FluGuard at Rs 35 per tablet
    New Delhi, August 4 (IANS) Sun Pharmaceutical Industries Ltd on Tuesday announced the launch of Favipiravir, under brand name FluGuard, at Rs 35 per tablet for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is an oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease. The stocks of FluGuard will be available in the market from this week, Sun Pharma said. "With over 50,000 Covid-
  • Wockhardt wins UK govt deal on Covid-19 vaccine manufacturing
    Mumbai, Augùst 3 (IANS) Mumbai-headquartered pharmaceutical company Wockhardt on Monday announced that it has entered into an agreement with the UK government to fill-finish millions of doses of Covid-19 vaccines. As per the terms of the agreement, the company has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK government in its fight against Covid-19, including AZD1222, the vaccine co-invented by the University of Oxford and its spin-ou
  • Centre issues guidelines for reopening of gyms from Aug 5
    New Delhi, August 3 (IANS) From maintaining a distance of six feet, using visor rather than mask, following respiratory etiquette, the Ministry of Health and Family Welfare on Monday issued guidelines for re-opening of gyms and yoga centres as a part of the third phase of easing of lockdown. Yoga institutes and gymnasiums are slated to open from August 5. The guidelines aim to minimize possible physical contacts between staff, members and visitors and maintain social distancing, oth
  • Serum gets nod for phase 2, 3 trials of vaccine
    New Delhi, August 3 (PTI): The Drugs Controller General of India has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country.        Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendation
  • Covid pandemic, systemic racism are inextricably linked: Study
    New York, Aug 2 (IANS) Frontline health workers from Black, Asian and minority ethnic backgrounds faced much higher risks of testing positive for Covid-19 than individuals in the general community during the peak of the deadly respiratory disease, new research has found. The findings demonstrated how the Covid-19 pandemic and systemic racism are inextricably linked and need immediate attention. Black, Asian, and minority ethnic healthcare workers appeared to be disproportionately
  • Russia plans mass COVID-19 vaccination for October
    Moscow, August 2 (IANS) Russia is planning a mass vaccination campaign against the novel coronavirus for October, Health Minister Mikhail Murashko said. "We plan wider (vaccination) for October because we need to launch a new system of treatment gradually," the Minister told TASS News Agency on Saturday. Murashko pointed out earlier that clinical trials of a coronavirus vaccine developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology were
  • Breathing exercises can help students manage mental stress
    New York, Aug 1 (IANS) Researchers have revealed that well-being strategies such as breathing exercises can improve mental health in college students and manages stress and anxiety. The research team evaluated three classroom-based wellness training programs that incorporate breathing and emotional intelligence strategies, finding that two led to improvements in aspects of wellbeing. The most effective programme led to improvements in six areas, including depression and social co
  • EU signs deal on Remdesivir supply for COVID-19 treatment
    Brussels, July 30 (IANS) The European Commission said that it has signed a 63 million-euro contract with American pharmaceutical company Gilead to secure doses of Veklury, the brand name for Remdesivir, for the treatment of COVID-19. The Commission said in a statement on Wednesday that batches of Veklury will be made available to the EU member states and the UK from early August, reports Xinhua news agency. The distribution will be coordinated by the European Commission. Remde
  • Nearly one in three children have dangerous amounts of lead in bloodstream - study
    NEW DELHI, July 30 (Reuters): Nearly one in three children around the world have high levels of lead in their bloodstream, according to a new study, as widespread lead pollution puts millions of young people at risk of irreversible mental and physical damage. Some 800 million children had lead levels of 5 micrograms per decilitre or higher in their bloodstream, the study carried out by United Nations agency UNICEF and environmental group Pure Earth showed, levels considered hig
  • Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK
    PARIS, July 29 (Reuters) - Sanofi and GSK said they had reached an agreement with Britain to supply it with up to 60 million doses of a potential COVID-19 vaccine, and that discussions with other governments were ongoing. No vaccine has yet been approved to treat or prevent COVID-19, the respiratory disease caused by the new coronavirus which has killed more than 659,000 people and triggered economic havoc worldwide. Financial terms of the agreement were not disclosed. Sanofi and
  • Vaccine alliance eyes range of prices for COVID shots, says $40 would be maximum
    LONDON/CHICAGO, July 28 (Reuters) - Coordinators of a global coronavirus vaccines funding scheme are looking at a wide range of potential prices for COVID-19 shots, with a reported $40 per dose price tag the “highest number” in that range, one of the co-leads of the project said on Monday. Seth Berkley, chief executive of the GAVI vaccine alliance, which is co-leading the COVAX facility designed to ensure fair global access to COVID-19 shots, said the facility had no spe
  • Moderna, Pfizer start decisive COVID-19 vaccine trials, eye year-end launches
    July 28, (Reuters)- Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday. The trials, both announced on Monday, are the first late-stage studies supported by the Trump administration’s effort to speed development of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic. M
  • Human trial of Covaxin begins at Odisha hospital
    New Delhi, July 27 (PTI): The human clinical trial of indigenously developed Covaxin, a possible vaccine against the novel coronavirus, began at an institute here on Monday, a senior official said. The much-awaited trial of BBV152 COVID-19 vaccine or Covaxin commenced at the Institute of Medical Sciences and SUM Hospital, one of the 12 centres selected by Indian Council of Medical Research (ICMR) for conducting phase one and two of the process, the official at the facility said.
  • Wealthier men more likely to develop high blood pressure
    Tokyo, July 27 (IANS) Working men with higher incomes are nearly twice as likely to develop high blood pressure than men who have a lower income, say researchers. More than one billion people have high blood pressure worldwide. Around 30-45 per cent of adults are affected. High blood pressure is the leading global cause of premature death, accounting for almost 10 million deaths in 2015. Of those, 4.9 million were due to ischaemic heart disease and 3.5 million were due to stroke.
  • Big B on how Covid-19 affects mental health
    Mumbai, July 26 (IANS) Megastar Amitabh Bachchan, who is currently seeking Covid-19 treatment at Nanavati Hospital in Mumbai, has opened up on the alarming effects of the deadly virus on the mental health of the patients. Taking to his blog, Big B penned a lengthy note, saying, "In the darkness of the night and the shiver of the cold room, I sing... eyes shut in attempted sleep... there is no one about or around... and the freedom to be able to do that will extend I know if in
  • Breast cancer rates rising rapidly around the world: Lancet
    Toronto, July 26 (IANS) In a study conducted in 41 countries, the researchers have revealed that breast cancer rates among women are on the rise globally. The research, published in the journal The Lancet Global Health, found that in higher-income nations rates of breast cancer in premenopausal women are increasing, while postmenopausal breast cancer is increasing more rapidly in lower-income countries. Although breast cancer is thought to be a disease of the developed world, alm
  • Researchers identify 21 existing drugs that could treat Covid-19
    New York, July 25 (IANS) A global team of scientists has identified 21 existing drugs that stop the replication of SARS-CoV-2, the virus that causes COVID-19. Notably, four of these compounds were found to work synergistically with remdesivir, a current standard-of-care treatment for Covid-19, said the study published in the journal Nature. "Remdesivir has proven successful at shortening the recovery time for patients in the hospital, but the drug doesn't work for everyo
  • Too much hand sanitiser can lead to severe hand dermatitis
    New Delhi, July 25 (IANSlife) Hand sanitisers have irrefutably become the most important thing in our lives to protect ourselves during the ongoing Covid-19 pandemic; the other things include masks and social distancing. It has been a long time since hand sanitisers became mandatory; while they are effective in dealing with germs and bacteria, excessive usage can result in killing good bacteria as well. Citing medical reports, alcohol-based sanitisers are considered effective in eli